author-photo

Stephen M. Keefe

University of Pennsylvania

55

Papers

858

Citations

Citation Trend

Filter By

Papers (40) Sort By

Journal Conference Others

Pembrolizumab (pembro) as first-line therapy in elderly patients (pts) with poor performance status with cisplatin-ineligible advanced urothelial cancer (UC): Results from Keynote-052

2018 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (1)
Phase 2 study of pembrolizumab in patients with bacillus Calmette-Guérin–unresponsive, high-risk, non–muscle-invasive bladder cancer: KEYNOTE-057

2018 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (0)
A phase II trial of an oral CDK 4/6 inhibitor, PD0332991, in advanced breast cancer.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (17)
SDHB mutation carriers with malignant pheochromocytoma respond better to CVD

2017 Endocrine-related Cancer
Show All
- Source
- Cite
- Save
Citations (22)
Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (40)
Pembrolizumab as first-line therapy in cisplatin-ineligible advanced urothelial cancer: Results from the total KEYNOTE-052 study population.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (45)
Reaffirming and Clarifying the American Society of Clinical Oncology’s Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (16)
Efficacy of the nanoparticle–drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I–IIa clinical trial

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (25)
Axitinib in combination with pembrolizumab in patients (pts) with advanced renal cell carcinoma (aRCC): Preliminary safety and efficacy results

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (24)
Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer

2016 Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (12)